Mercado Global de Hematologia e Citometria de Fluxo Point of Care (POC) – Tendências do setor e previsão para 2028

Análise de mercado e insights de hematologia e citometria de fluxo no ponto de atendimento (POC)

Espera-se que o mercado de hematologia e citometria de fluxo no ponto de atendimento (POC) ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa o mercado para contabilizar 4.920,92 milhões de dólares até 2028 e crescerá a um CAGR de 7,86% no período de previsão acima referido.

A hematologia é uma subdivisão ou ramo da medicina que envolve o estudo e tratamento do sangue. Enquanto a citometria de fluxo examina todo o componente do sangue e é uma tecnologia biofísica baseada em laser que está envolvida na contagem de células, classificação de células , detecção de proteínas e detecção de biomarcadores. 

A elevada adoção de técnicas de citometria de fluxo na investigação e na academia está entre os fatores importantes que deverão intensificar o crescimento e a procura do mercado de hematologia e citometria de fluxo no ponto de atendimento (POC). Além disso, espera-se também que o aumento da população geriátrica e o aumento dos investimentos dos organismos governamentais para melhorar as instalações de saúde contribuam para o crescimento do mercado global durante o período previsto de 2021 a 2028. Também a elevada adoção de produtos tecnologicamente avançados e o O aumento das iniciativas público-privadas no domínio da imunologia e da investigação imuno-oncológica também irá provavelmente aumentar o crescimento do mercado. Além disso, os rápidos avanços tecnológicos e o aumento da disponibilidade de produtos específicos para aplicações também estão entre os fatores significativos que deverão alimentar o crescimento do mercado de hematologia e citometria de fluxo no ponto de atendimento (POC).   

Prevê-se que a elevada adoção da tecnologia de ADN recombinante para a produção de anticorpos, o aumento do pipeline para a investigação com células estaminais e a rápida evolução das tecnologias de citometria de fluxo em tandem ofereçam oportunidades de crescimento significativas para o mercado da hematologia e citometria de fluxo no ponto de atendimento (POC) na previsão período de 2021 a 2028.

However, the limited purchasing power of end users and high product costs are expected to curb the growth of the point of care (POC) hematology and flow cytometry market, whereas the availability of cheaper and better substitutes for flow cytometry can challenge the growth of the point of care (POC) hematology and flow cytometry market.

This point of care (POC) hematology and flow cytometry market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on point of care (POC) hematology and flow cytometry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Point of Care (POC) Hematology and Flow Cytometry Market Scope and Market Size

Point of care (POC) hematology and flow cytometry market is segmented on the basis of product type, technology and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product type, the point of care (POC) hematology and flow cytometry market is segmented into flow cytometry instruments, reagent and consumables and accessories. Flow cytometry instruments have further been segmented into cell analyzers and cell sorters.
• The technology segment of the point of care (POC) hematology and flow cytometry market is segmented into bead-based flow cytometry and cell-based flow cytometry.
• On the basis of end user, the point of care (POC) hematology and flow cytometry market is segmented into biotechnology and pharmaceutical companies, hospitals, clinics, research centers, clinical testing laboratories, academics and others. 

Point of Care (POC) Hematology and Flow Cytometry Market Country Level Analysis

Point of care (POC) hematology and flow cytometry market is analyzed and market size insights and trends are provided by country, product type, technology and end user as referenced above.

The countries covered in the point of care (POC)  hematology and flow cytometry market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the point of care (POC) hematology and flow cytometry market owing to the increase in the demand for improved efficiency and rise in the government initiatives. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the high growth in the pharmaceutical and biotechnology industries in the emerging economies such as India and China.             

The country section of the point of care (POC) hematology and flow cytometry market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Point of care (POC) hematology and flow cytometry market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point of care (POC) hematology and flow cytometry market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care (POC) hematology and flow cytometry market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Point of Care (POC) Hematology and Flow Cytometry Market Share Analysis

O panorama competitivo do mercado de hematologia e citometria de fluxo no ponto de atendimento (POC) fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado da hematologia e citometria de fluxo no ponto de atendimento (POC).

Os principais players abordados no relatório de mercado de hematologia e citometria de fluxo no ponto de atendimento (POC) são Abbott, Agilent Technologies, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc., BD, Bio-Rad Laboratories, Inc., Horiba, Lda., NIHON KOHDEN CORPORATION, Cardinal Health, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Sysmex Europe GmbH, Merck KGaA, Luminex Corporation, Sony Biotechnology Inc., Takara Bio Inc., Enzo Life Sciences, Inc., bioMérieux SA e Cytek Biosciences, entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-63155